Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 6/2011

01.12.2011

Androgens are Fundamental in the Maintenance of Male Sexual Health

verfasst von: Alvaro Morales

Erschienen in: Current Urology Reports | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

The presence of a sufficient amount of androgens is essential for adequate sexual function in men. Gonadal hormones profoundly affect cognitive functions and, therefore, are fundamental in maintaining sexual desire. The earliest manifestation of hypogonadism is diminished libido. Furthermore, androgens also act peripherally, maintaining the integrity of penile structures and facilitating the erectile mechanisms. Severe androgen deficiency results in anatomical and hemodynamic changes leading to erectile dysfunction that can be corrected with testosterone supplementation.
Literatur
1.
Brown-Séquard CE. Note on the effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals. Lancet. 1889;137:105–7.CrossRef
2.
David K, Dingemanse E, Laqeur E. Uber kristallinisches m männliches Hormon aus Hoden (Testosteron), wirksamer aus Harn oder aus Cholesterin bereitetes Androsteron. Z Physiol Chem. 1935;233:281–7.CrossRef
3.
King SR, Manna PR, Ishii T, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci. 2002;15(22):10613–20.
4.
Mulligan T, Iranmanesh A, Feldhuis JD, et al. Pulsatile IV infusion of recombinant human LH in leuprolide suppressed men unmasks impoverished Leydig-cell secretory responsiveness. J Clin Endocrinol Metab. 2001;86:5574–9.CrossRef
5.
Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335–43.PubMedCrossRef
6.
Montejo AL, Majadas S, et al. Frequency of sexual dysfunction in patients with psychotic disorder receiving antipsychotics. J Sex Med. 2010;7:3404–13.PubMedCrossRef
7.
Elaut E, Bogaert V, De Cuypere G, et al. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: en exploration in male-to-female transsexuals. J Endocrinol Invest. 2010;33:37–41.PubMed
8.
• Gades NM, Jacobson DJ, McGree ME, et al. The association between serum sex hormones, erectile function, and sex drive: The Olmsted County Study of urinary symptoms and health status among men. J Sex Med. 2008;5:2209–20. This study provides strong support to the clinical relevance of androgens and sexual function.PubMed
9.
Buvat J, Lemaire A. Endocrine screening of 1022 men with erectile dysfunction: clinical significance and cost effective strategy. J Urol. 1997;158:1764–8.PubMedCrossRef
10.
Johri AM, Heaton JPW, Morales A. Severe erectile dysfunction is a marker of hyperprolactinemia. Int J Impot Res. 2001;13:176–9.PubMedCrossRef
11.
Lobo RA, Kletzky OA. Normalization of androgens and sex-hormone-binding globulin levels after treatment of hyperprolactinemia. J Clin Endocrinol Metab. 1982;56:562–6.CrossRef
12.
• Rowland D, McMahon CG, Abdo C, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7:1668–86. This is an excellent current review of androgens and effect on men’s health.PubMedCrossRef
13.
Lauman EO, Paik A, Rosen RC. Sexual dysfunctions in the United States: prevalence and predictors. JAMA. 1999;281:537–44.CrossRef
14.
15.
Corona G, Mannuci E, Lotti F, et al. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. J Sex Med. 2009;6:2591–600.PubMedCrossRef
16.
Arteaga-Silva M, Vigueras-Villasenor RM, Retana-Marquez S, et al. Testosterone, androstenedione and 5 alpha-dehydrotestosterone on male sexual behavior and penile spines in the hamster. Physiol Behav. 2008;94:412–21.PubMedCrossRef
17.
Sarkar M, Bora D, Bandopadhayay S, et al. Season of the year influences output and concentration of testosterone in circulation in yaks. Anim Reprod Sci. 2009;115:300–5.PubMedCrossRef
18.
Corona G, Jannini EA, Mannuci E, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5:1991–8.PubMedCrossRef
19.
Heaton JPW, Varrin S, Morales A. The characterization of a bio-assay of erectile function in a rat model. J Urol. 1991;145:1099–102.PubMed
20.
Adams MA, Banting JD, Maurice DH, et al. Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple overlapping systems. Int J Impot Res. 1997;9:85–9.PubMedCrossRef
21.
Traish AM, Munarriz R, O’Conell L, et al. Effects of medical or surgical castration on erectile function in an animal model. J Androl. 2003;24:381–7.PubMed
22.
Morales A, Johnson B, Heaton JPW, et al. Testosterone supplementation in hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol. 1997;157:849–52.PubMedCrossRef
23.
Saad F, Gooren LJ, Haider A, et al. A dose response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl. 2008;29:102–6.PubMedCrossRef
24.
Hwang TI, Lin YC. The relationship between hypogonadism and erectile dysfunction. Int J Impot Res. 2008;20:231–5.PubMedCrossRef
25.
Hirshkowitz M, Moore CA, O’Connor S, et al. Androgens and sleep-related erections. J Psychosom Res. 1997;42:541–7.PubMedCrossRef
26.
Kalinchenko SY, Koslov GI, Gontcharov NP, et al. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus on patients failing on sildenafil citrate therapy alone. Aging Male. 2003;6:94–9.PubMed
27.
Rosenthal BD, May NR, Metro MJ, et al. Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology. 2006;67:571–4.PubMedCrossRef
28.
29.
Brindley GS. Cavernosal alpha blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatr. 1983;143:332–7.CrossRef
30.
Brindley GS. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. Br J Psychiatr. 1986;149:210–5.CrossRef
31.
Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–36.PubMed
32.
Saenz de Tejada I. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int J Impot Res. 2002;14 Suppl 1:6–10.CrossRef
33.
Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191–236.PubMed
34.
• Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection. J Androl. 2009;30:363–9. This is an informative review of the basic science efforts to elucidate the effect of androgen deprivation in erectile function.PubMedCrossRef
35.
• Bhasin S, Cunningham G, Hayes F, et al. Testosterone therapy in men with androgen deficiency syndromes: En Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:2536–59. This article is essential reading for those treating men with TDS.PubMedCrossRef
36.
Morales A, Bella AJ, Chun S, et al. A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Can Urol Assoc J. 2010;4:269–75.PubMed
37.
Bhasin S, Coviella A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.PubMedCrossRef
38.
Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239–42.PubMedCrossRef
39.
Morales A, Spevack L, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male. 2007;10:57–65.PubMedCrossRef
40.
Hackett G, Kell P, Ralph D, et al. British society for sexual medicine guidelines on the management of erectile dysfunction. J Sex Med. 2008;5:1841–65.PubMedCrossRef
41.
Wang C, Nieschlag EE, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009;55:121–30.PubMedCrossRef
42.
• Collier C, Morales A, Clark AF, et al. The significance of biological variation in the diagnosis of testosterone deficiency and considerations on the relevance of total, free and bioavailable testosterone determinations. J Urol. 2010;183:2294–8. This is an informative study on the pitfalls of biochemical assays for measuring serum testosterone.PubMedCrossRef
43.
Black A, Day AG, Morales A. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJUI. 2004;94:1066–70.CrossRef
44.
45.
Melmed S, Casanova FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactenemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:272–8.CrossRef
46.
Kupelian V, Shabsigh R, Araujo AB, et al. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts male aging study. J Urol. 2006;176:222–6.PubMedCrossRef
47.
Corona G, Monami M, Rastrelli G, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011;8:272–83.PubMedCrossRef
48.
• Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93:69–75. This study refuted the erroneous idea that TDS is merely an inconvenience that does not affect survival or quality of life, a wake-up call for clinicians.
49.
Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241–7.PubMedCrossRef
50.
Morales A, Nieschlag E, Schubert M, et al. Clinical experience with the new long-acting injectable testosterone undecanoate. Aging Male. 2006;9:221–7.PubMedCrossRef
51.
Foresta C, Caretta N, Rossato M, et al. Role of androgens in erectile function. J Urol. 2004;171:2358–62.PubMedCrossRef
52.
Saad F, Grahl AS, Aversa A, et al. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJUI. 2007;99:968–92.CrossRef
53.
Aversa A, Isidori AM, Spera G, Lenzi A, et al. Androgens improve cavernous vasodilatation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632–8.CrossRef
54.
Shabsigh R, Kaufman KJ, Steidle C, et al. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172:658–63.PubMedCrossRef
55.
Greenstein A, Mabjeesh NJ, Sofer M, et al. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol. 2005;173:530–2.PubMedCrossRef
56.
Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST Study). J Sex Med. 2011;8:284–93.PubMedCrossRef
57.
Morales A, Schulman CC, Tostain JC, Wu WF. Testosterone deficiency syndrome (TDS) need to be named appropriately: the importance of accurate terminology. Eur Urol. 2006;50:407–9.PubMedCrossRef
58.
Morales A, Black A, Emerson L, et al. Androgens and sexual function: a placebo controlled, randomized, double blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. Aging Male. 2009;12:104–12.PubMedCrossRef
59.
Guay A, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial of clomiphene citrate. J Clin Endocrinol Metab. 1995;80:3546–52.PubMedCrossRef
Metadaten
Titel
Androgens are Fundamental in the Maintenance of Male Sexual Health
verfasst von
Alvaro Morales
Publikationsdatum
01.12.2011
Verlag
Current Science Inc.
Erschienen in
Current Urology Reports / Ausgabe 6/2011
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-011-0202-4

Weitere Artikel der Ausgabe 6/2011

Current Urology Reports 6/2011 Zur Ausgabe

Erectile Dysfunction (Thomas Lue, Section Editor)

Rise of Herbal and Traditional Medicine in Erectile Dysfunction Management

Erectile Dysfunction (Tom F. Lue, Section Editor)

Combination Surgery for Erectile Dysfunction and Male Incontinence

Overactive Bladder (Gopal Badlani, Section Editor)

Updates in the Management of the Overactive Bladder in Patients with Myelomeningocele

Clinical Trial Report

The Scientific Rationale for Using Biomaterials in Stress Urinary Incontinence and Pelvic Organ Prolapse

ReviewPaper

Penile Fracture and Penile Reconstruction

Erectile Dysfunction (Tom Lue, Section Editor)

Emerging and Novel Therapeutic Approaches in the Treatment of Male Erectile Dysfunction

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise